Stay updated on Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial

Sign up to get notified when there's something new on the Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision indicator was updated from v3.5.2 to v3.5.3, reflecting an incremental site/version change without altering the displayed clinical trial study content.
    Difference
    0.1%
    Check dated 2026-04-24T05:55:21.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Added an erratum note for the JCO 2018 publication. Updated the publication revision from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:41:30.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added. Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T06:09:04.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page's revision label updated from v3.4.2 to v3.4.3. No trial content or visible details appear to be altered.
    Difference
    0.1%
    Check dated 2026-03-12T02:22:18.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Updates shown are revision dates for the study record (e.g., 2026-03-04, 2027-02) and related metadata. No substantive changes to study design, eligibility criteria, outcomes, or locations are indicated.
    Difference
    0.3%
    Check dated 2026-03-04T23:42:46.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Added site revision note 'Revision: v3.4.2'. Removed the operating-status notice about lapse in government funding and the earlier 'Revision: v3.4.1' note.
    Difference
    0.4%
    Check dated 2026-02-11T14:21:39.000Z thumbnail image

Stay in the know with updates to Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial page.